Professor Neal Navani
Neal Navani qualified in Medicine from Cambridge University and UCL in 2000 with distinction and several University prizes. He trained in Respiratory Medicine at the Brompton and Hammersmith Hospitals before winning a Medical Research Council Fellowship in 2008 and completing his PhD at UCL in 2011. He has also completed an MSc in Clinical Trials and Biostatistics at the London School of Hygiene and Tropical Medicine.
Dr Navani is lead clinician for the lung cancer service at UCLH, and senior clinical lead of the National Lung Cancer Audit. He is also Clinical Director for the Centre for Cancer Outcomes for the North Central London Cancer Alliance. He is on the steering committee of the British Thoracic Oncology Group, UK Lung Cancer Coalition and on the Thoracic Oncology board of the American Thoracic Society.
Dr Navani is an Associate Professor at UCL. He currently holds >£1m of grant funding including a CRUK grant for the early diagnosis of lung cancer, a separate CRUK grant for developing novel methods for cancer data collection and NIHR funding for a study on predicting lung cancer with artificial intelligence. He has over 100 peer-reviewed publications. In 2020, Dr Navani won a prestigious MRC / NIHR fellowship to research predictors of cancer in lung nodules.
Dr Navani is lead clinician for the lung cancer service at UCLH, and senior clinical lead of the National Lung Cancer Audit. He is also Clinical Director for the Centre for Cancer Outcomes for the North Central London Cancer Alliance. He is on the steering committee of the British Thoracic Oncology Group, UK Lung Cancer Coalition and on the Thoracic Oncology board of the American Thoracic Society.
Dr Navani is an Associate Professor at UCL. He currently holds >£1m of grant funding including a CRUK grant for the early diagnosis of lung cancer, a separate CRUK grant for developing novel methods for cancer data collection and NIHR funding for a study on predicting lung cancer with artificial intelligence. He has over 100 peer-reviewed publications. In 2020, Dr Navani won a prestigious MRC / NIHR fellowship to research predictors of cancer in lung nodules.